Updated Apr 13, 2018

U.S. would send strongest trade message to China by rejoining TPP

Shipping containers at Chua Ve port in Hai Phong, Vietnam. Photo: Hoang Dinh Nam/AFP/Getty Images

President Trump has instructed his economic advisors to consider rejoining the Trans-Pacific Partnership (TPP), but economics is only part of the deal’s appeal. The TPP, now known as the CPTPP, was also crafted to advance U.S. foreign policy interests.

Why it matters: Rejoining would reaffirm America’s commitment to Asia, where China has become increasingly assertive. That’s why Japan is already welcoming the possibility with open arms.

There are other benefits that Trump’s defense and foreign policy advisors should take into account: The TPP also advances democratic norms by raising standards for governance, fighting corruption and promoting a free and open internet.

Many of those gains can be seen in the version of the deal that moved forward without U.S. participation. With the U.S. involved, other countries in the region will have an even greater incentive to adopt standards and rules that reflect American interests.

If the U.S. remains outside the TPP, it will only strengthen China, which is already advancing its own plans for Asia and beyond. President Xi Jinping’s Belt and Road Initiative, launched in 2013 in part as a response to the TPP, aims to put Beijing at the center of the global economy. It has attracted some 70 countries with promises of $1 trillion of infrastructure investment, trade deals and policy coordination.

The bottom line: In Asia, economics is strategy, and right now China is running the table.

Jonathan Hillman is a fellow and director of the Reconnecting Asia Project at the Center for Strategic and International Studies.

Go deeper

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3:30 p.m. ET: 838,061 — Total deaths: 41,261 — Total recoveries: 174,115.
  2. U.S.: Leads the world in confirmed cases. Total confirmed cases as of 3:30 p.m. ET: 177,452 — Total deaths: 3,440 — Total recoveries: 6,038.
  3. Public health updates: More than 400 long-term care facilities across the U.S. report patients with coronavirus — Older adults and people with other health conditions are more at risk, new data shows.
  4. Federal government latest: The White House and other institutions are observing several models to better understand and prepare cities for when the coronavirus is expected to peak in the U.S.
  5. In Congress: New York Rep. Max Rose deploys to National Guard to help coronavirus response.
  6. 🎧 Podcast: Misinformation in the coronavirus age.
  7. What should I do? Answers about the virus from Axios expertsWhat to know about social distancingQ&A: Minimizing your coronavirus risk.
  8. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

U.S. coronavirus updates: White House studies models projecting virus peak

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Andrew Witherspoon/Axios

The White House and other institutions are observing several models to better understand and prepare cities for when the coronavirus is expected to peak in the U.S.

The state of play: The coronavirus is expected to peak in the U.S. in two weeks, but many states like Virginia and Maryland will see their individual peaks well after that, according to a model by the University of Washington's Institute for Health Metrics and Evaluation.

Go deeperArrowUpdated 1 hour ago - Health

FDA authorizes two-minute antibody testing kit to detect coronavirus

Currently, it takes days to produce results from testing kits. Photo: Sergei Malgavko\TASS via Getty Images

The Food and Drug Administration issued an emergency approval Tuesday for a serological testing kit produced by Bodysphere Inc. that can detect a positive or negative result for COVID-19 in two minutes.

Why it matters: Access to testing has improved in the U.S. thanks to commercial labs, but the average wait time for a patient's results is four to five days — with some reports of it taking more than a week.

Go deeperArrowUpdated 2 hours ago - Health